Ligand validation:5WAU

PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE

PGV is a Ligand Of Interest in 5WAU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5WAU_PGV_C_303	59%	57%	0.175	0.958	0.85	0.8	2	1	0	0	100%	1
5WAU_PGV_A_607	58%	55%	0.178	0.958	0.87	0.85	2	3	0	0	100%	1
5WAU_PGV_a_607	51%	58%	0.2	0.957	0.85	0.75	2	2	0	0	100%	1
5WAU_PGV_c_306	51%	56%	0.19	0.944	0.9	0.81	2	1	0	0	100%	1
5WAU_PGV_C_304	5%	47%	0.242	0.651	1.07	0.99	2	4	0	0	100%	1
5WAU_PGV_A_606	2%	49%	0.337	0.646	1.03	0.93	2	3	0	0	100%	1
5WAU_PGV_c_302	2%	41%	0.309	0.554	1.06	1.21	2	5	0	0	100%	1
5WAU_PGV_a_606	0%	42%	0.428	0.427	1.07	1.17	2	5	0	0	100%	1
5B1A_PGV_P_303	98%	35%	0.064	0.985	1.06	1.51	3	13	4	0	100%	1
5X1B_PGV_C_302	95%	52%	0.078	0.981	0.92	0.93	2	4	0	0	100%	1
5B1B_PGV_C_302	94%	56%	0.078	0.979	0.81	0.87	1	1	3	0	100%	1
7YPY_PGV_P_302	94%	54%	0.079	0.978	0.79	0.99	2	2	1	0	100%	1
7COH_PGV_C_267	93%	49%	0.087	0.983	0.87	1.09	3	3	0	0	100%	1
5ZCQ_PGV_N_608	90%	32%	0.094	0.978	1.15	1.53	5	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.